These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2521045)

  • 1. Amrinone: pharmacokinetics and pharmacodynamics.
    Levy JH; Bailey JM
    J Cardiothorac Anesth; 1989 Dec; 3(6 Suppl 2):10-4. PubMed ID: 2521045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative experience with amrinone.
    Levy JH; Bailey JM
    Eur J Anaesthesiol Suppl; 1992; 5():15-9. PubMed ID: 1600963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of amrinone during cardiac surgery.
    Bailey JM; Levy JH; Rogers HG; Szlam F; Hug CC
    Anesthesiology; 1991 Dec; 75(6):961-8. PubMed ID: 1741517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute pharmacokinetics and pharmacodynamics of amrinone in pediatric patients.
    Lawless ST; Zaritsky A; Miles M
    J Clin Pharmacol; 1991 Sep; 31(9):800-3. PubMed ID: 1804862
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemodynamic effects of amrinone during emergence from cardiopulmonary bypass].
    Nakata F; Ka H; Yamamoto H; Nammpo T; Yoshikawa H
    Masui; 1995 Dec; 44(12):1632-8. PubMed ID: 8583658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amrinone: its effect on vascular resistance and capacitance in human subjects.
    Levy JH; Bailey JM
    Chest; 1994 Jan; 105(1):62-4. PubMed ID: 8275786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of amrinone, a phosphodiesterase inhibitor, on right ventricular/arterial coupling immediately after cardiac operations.
    Ochiai Y; Morita S; Tanoue Y; Kawachi Y; Tominaga R; Yasui H
    J Thorac Cardiovasc Surg; 1998 Jul; 116(1):139-47. PubMed ID: 9671908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of amrinone during continuous veno-venous haemofiltration after cardiac surgery.
    Hellinger A; Wolter K; Marggraf G; Pentz R; Fritschka E
    Eur J Clin Pharmacol; 1995; 48(1):57-9. PubMed ID: 7621849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amrinone in neonates and infants after cardiac surgery.
    Lawless S; Burckart G; Diven W; Thompson A; Siewers R
    Crit Care Med; 1989 Aug; 17(8):751-4. PubMed ID: 2752768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodynamic effects of amrinone, phosphodiesterase inhibitor, early after coronary artery bypass grafting].
    Shibata T; Suehiro S; Minamimura H; Sasaki Y; Ishikawa T; Hattori K; Kinoshita H
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Nov; 44(11):2027-31. PubMed ID: 8958718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium inhibits the cardiac stimulating properties of dobutamine but not of amrinone.
    Butterworth JF; Zaloga GP; Prielipp RC; Tucker WY; Royster RL
    Chest; 1992 Jan; 101(1):174-80. PubMed ID: 1729065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of amrinone in children after Fontan surgery.
    Sorensen GK; Ramamoorthy C; Lynn AM; French J; Stevenson JG
    Anesth Analg; 1996 Feb; 82(2):241-6. PubMed ID: 8561320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, randomized, blind comparison of amrinone with milrinone after elective cardiac surgery.
    Rathmell JP; Prielipp RC; Butterworth JF; Williams E; Villamaria F; Testa L; Viscomi C; Ittleman FP; Baisden CE; Royster RL
    Anesth Analg; 1998 Apr; 86(4):683-90. PubMed ID: 9539583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amrinone (Wincoram)--a new positive inotropic and vasodilator agent].
    Hess W
    Anaesthesist; 1988 Jul; 37(7):400-7. PubMed ID: 3046413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive inotropic and vasodilating effects of amrinone and milrinone in isolated canine heart.
    Sys SU; Boels PJ; Brutsaert DL
    J Cardiovasc Pharmacol; 1987 Oct; 10(4):445-9. PubMed ID: 2444798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of venodilatory effect of amrinone and theophylline in human subjects.
    Harada K; Ohashi K; Kumagai Y; Fujimura A
    J Clin Pharmacol; 1995 Nov; 35(11):1067-70. PubMed ID: 8626879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amrinone. A preliminary review of its pharmacological properties and therapeutic use.
    Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Dec; 26(6):468-502. PubMed ID: 6360634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of amrinone in children after cardiac surgery.
    Berner M; Jaccard C; Oberhansli I; Rouge JC; Friedli B
    Intensive Care Med; 1990; 16(2):85-8. PubMed ID: 2332544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inotropic and vasodilating properties of amrinone depend on the mode of administration.
    Hartog JM; Saxena PR; Verdouw PD
    Eur Heart J; 1986 Dec; 7(12):1067-76. PubMed ID: 3830202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of intravenous amrinone in the short-term management of refractory heart failure in pregnancy.
    Jelsema RD; Bhatia RK; Ganguly S
    Obstet Gynecol; 1991 Nov; 78(5 Pt 2):935-6. PubMed ID: 1923233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.